Report : Asia Pacific Nasal Irrigation Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Manual Nasal Irrigators, Electric Nasal Irrigators, and Battery-Powered Nasal Irrigators), Patient Type (Pediatrics and Adult), Application (Rhinitis, Sinus, Bronchiolitis, Post-Operative Respiratory Conditions, and Others), and End User (Hospitals & Clinics, Home Care, and Others)
At 18.8% CAGR, the Asia Pacific Nasal Irrigation Devices Market is speculated to be worth US$ 205.93 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific nasal irrigation devices market was valued at US$ 73.10 million in 2022 and is expected to reach US$ 205.93 million by 2028, registering a CAGR of 18.8% from 2022 to 2028. Upsurge in allergies and infectious diseases and cumulative awareness among patients and benefits offered by nasal irrigation are the critical factors attributed to the Asia Pacific nasal irrigation devices market expansion.
Nasal irrigation is a process of cleaning the nasal cavity by using irrigation devices, which helps in the removal of debris, mucus, and allergens. Over the past few years, there has been significant growth in allergies and infectious diseases, affecting the upper respiratory tract and increasing the demand for nasal irrigation solutions. There has been a significant surge in sinus, rhinitis, bronchiolitis, and other post-operative conditions among people, which require nasal irrigation for a speedy recovery. These conditions can lead to increased inflammation and deposition of bacteria, which can further worsen the condition. Therefore, the increasing prevalence of sinusitis has affected an individual’s activities, aiding the demand for nasal irrigation and driving the nasal irrigation devices market. The surge in the prevalence of upper respiratory tract infections due to increasing industrialization and pollution is also fueling the demand for nasal irrigation devices. The increase in pollution is resulting in a surge in allergens and pollutants, leading to nasal passage blockage, and excessive deposition of such chemicals or substances can further lead to sinusitis and other nasal problems. Furthermore, constantly changing lifestyles in developing and developed economies have increased the practice of nasal cavity washing to reduce allergic reactions, remove debris, and help relieve cold and flu. Thus, numerous benefits of nasal irrigation and a high adoption rate of nasal irrigation devices among a large population are supporting the growth of this market. This is expected to drive the Asia Pacific nasal irrigation devices market during the forecast period.
On the contrary, challenges linked with nasal irrigation devices hurdles the growth of Asia Pacific nasal irrigation devices market.
Based on product type, the Asia Pacific nasal irrigation devices market is categorized into manual nasal irrigators, electric nasal irrigators, and battery powered nasal irrigators. The manual nasal irrigators segment held 46.0% market share in 2022, amassing US$ 33.61 million. It is projected to garner US$ 91.28 million by 2028 to expand at 18.1% CAGR during 2022–2028.
Based on patient type, the Asia Pacific nasal irrigation devices market is bifurcated into pediatrics and adult. The adult segment held 59.0% of the Asia Pacific nasal irrigation devices market share in 2022, amassing US$ 43.16 million. It is projected to garner US$ 124.32 million by 2028 to expand at 19.3% CAGR during 2022–2028.
Based on application, the Asia Pacific nasal irrigation devices market is categorized into rhinitis, sinus, bronchiolitis, post-operative respiratory conditions, and others. The sinus segment held 31.8% market share in 2022, amassing US$ 23.21 million. It is projected to garner US$ 67.66 million by 2028 to expand at 19.5% CAGR during 2022–2028.
Based on end user, the Asia Pacific nasal irrigation devices market is categorized into hospitals & clinics, home care, and others. The home care segment held 39.7% market share in 2022, amassing US$ 29.00 million. It is projected to garner US$ 84.45 million by 2028 to expand at 19.5% CAGR during 2022–2028.
Based on country, the Asia Pacific nasal irrigation devices market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 36.1% market share in 2022. It was assessed at US$ 26.41 million in 2022 and is likely to hit US$ 77.86 million by 2028, exhibiting a CAGR of 19.7% during the forecast period.
Key players dominating the Asia Pacific nasal irrigation devices market are Air Liquide Medical Systems; Neilmed Pharmaceuticals Inc.; Stryker Corp; Heal Force; Bremed Ltd.; Medtronic Plc; and Bayer AG among others.
- In Nov 2021, NeilMed Pharmaceuticals kicks off Sonoma County expansion as exports of nasal care products grow.
- In June 2019, Air Liquide reinforces its presence in Asia Pacific with the acquisition of Medidis in the Netherlands.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org